AS Malaysia grapples with rising medical inflation and intensifying debate over insurance reform, policymakers are increasingly looking outwards for answers.
Diagnosis-related groups (DRGs), standardised benefits, community rating and co-payments are often cited as “proven” tools, borrowed from advanced health systems such as Singapore, Australia, Europe and the United States.
